Details for Patent: 5,571,817
✉ Email this page to a colleague
Summary for Patent: 5,571,817
Title: | Methods of treating androgenic alopecia with finasteride [17.beta.-N-mono-substituted-carbamoyl-4-aza-5-.alpha.-androst-1-en-ones] |
Abstract: | 17.beta.-N-monosubstituted-carbamoyl-4-5.alpha.-androst-1-en-3-ones of the formula ##STR1## wherein R.sup.1 is selected from hydrogen, methyl and ethyl and R.sup.2 is a branched chain alkyl of from 3-12 carbons, and R', R", R'" are hydrogen or methyl are active as testosterone 5.alpha.-reductase inhibitors and thus are useful topically for treatment of androgenic alopecia. |
Inventor(s): | Rasmusson; Gary H. (Watchung, NJ), Reynolds; Glenn F. (Westfield, NJ) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 08/094,815 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,571,817
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,571,817
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 46912 | ⤷ Try a Trial | |||
Austria | 67503 | ⤷ Try a Trial | |||
Austria | 78827 | ⤷ Try a Trial | |||
Australia | 2748192 | ⤷ Try a Trial | |||
Australia | 3313589 | ⤷ Try a Trial | |||
Australia | 3916785 | ⤷ Try a Trial | |||
Australia | 584321 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |